Join
Live feed
·
PRReleasevia Quantisnow
ARS Pharmaceuticals Inc. logo

ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)

ByQuantisnow·Wall Street's wire, on your screen.
SPRY· ARS Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRY (ARS Pharmaceuticals Inc.) and more on Quantisnow.